Jenburkt Pharmaceuticals Limited (NSE:JENBURPH)
India · Delayed Price · Currency is INR 953.75
-20.25 (-2.08%)
At close: Nov 9, 2026
Jenburkt Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 1,711 | 1,687 | 1,517 | 1,420 | 1,367 | 1,240 |
Revenue Growth | 7.60% | 11.24% | 6.85% | 3.82% | 10.30% | 13.44% |
Gross Profit Gross Profit Growth | 1,359 | 1,350 | 1,209 | 1,106 | 1,029 | 918.3 |
Operating Income Operating Income Growth | 391.43 | 425.06 | 376.81 | 307.84 | 281.88 | 254.37 |
Net Income Net Income Growth | 328.76 | 347.36 | 320.61 | 259.77 | 246.07 | 222.97 |
Earnings Per Share EPS Growth | 74.50 | 78.71 | 72.65 | 58.86 | 53.90 | 48.58 |
EPS Growth | -0.36% | 8.34% | 23.42% | 9.21% | 10.93% | 35.12% |
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 1,422 | 1,323 | 1,216 | 1,109 | 1,027 |
Exports Exports Growth | 261.2 | 190.48 | 200.23 | 252.58 | 210.26 |
Total Total Growth | 1,683 | 1,514 | 1,416 | 1,361 | 1,237 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 815.11 | 473.16 | 231.43 | 739.69 | 494.84 | 465.86 |
Total Debt Total Debt Growth | 22.52 | 24.88 | 38.94 | - | 29.28 | 67.55 |
Net Cash (Debt) Net Cash Growth | 792.59 | 448.28 | 192.5 | 739.69 | 465.57 | 398.31 |
Net Cash Growth | 898.14% | 132.88% | -73.98% | 58.88% | 16.89% | -15.15% |
Net Cash Per Share Net Cash Per Share Growth | 179.60 | 101.57 | 43.62 | 167.61 | 101.97 | 86.79 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 266.07 | 265.22 | 279.06 | 81.24 | 170.52 | 92.71 |
Capital Expenditures CapEx Growth | -124.72 | -137.17 | -197.14 | -25.54 | -21.05 | -30.54 |
Free Cash Flow Free Cash Flow Growth | 141.35 | 128.05 | 81.92 | 55.7 | 149.48 | 62.17 |
Free Cash Flow Growth | - | 56.30% | 47.09% | -62.74% | 140.43% | -66.05% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 79.44% | 79.98% | 79.68% | 77.92% | 75.24% | 74.07% |
Operating Margin | 22.88% | 25.19% | 24.84% | 21.68% | 20.61% | 20.52% |
Pretax Margin | 25.20% | 27.57% | 28.96% | 24.78% | 24.03% | 24.09% |
Profit Margin | 19.21% | 20.59% | 21.14% | 18.30% | 17.99% | 17.98% |
FCF Margin | 8.26% | 7.59% | 5.40% | 3.92% | 10.93% | 5.01% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 20.700 | 20.700 | 18.000 | 15.300 | 14.400 | 12.000 |
Dividend Per Share Growth | 0% | 15.00% | 17.65% | 6.25% | 20.00% | 17.65% |
Dividend Yield | 2.17% | 2.17% | 1.78% | 2.22% | 2.16% | 2.12% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 11, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 12.80 | 12.14 | 13.93 | 11.71 | 11.95 | 11.66 |
P/FCF Ratio | 29.97 | 32.93 | 54.50 | 54.63 | 19.66 | 41.83 |
PS Ratio | 2.47 | 2.50 | 2.94 | 2.14 | 2.15 | 2.10 |